Current perspectives on the use of GLP-1 receptor agonists in obesity-related obstructive sleep apnea: a narrative review
People taking GLP-1s shed pounds because these drugs suppress appetite and increase feelings of fullness, in part by slowing the rate at which food moves through the digestive system
To read more of Michaels research, go to his Substack Dynamic Medicine for Complex Disease : References : Fnichel P, Coquillard P, Brucker-Davis F, Marchand P, Cano-Sancho G, Boda M, Antignac JP, Iannelli A, Gugenheim J, Le Bizec B, Chevalier N
McEwen BS, Nasca C, Gray JD
Lillys Easy-to Use Once-Weekly GLP-1 Agonist Trulicity Approved in Europe August 14, 2021 GLP-1 Agonists: From 2 Daily Injections to 1 Per Week and Beyond A review of how far GLP-1 agonists have come drugs for type 2 diabetes that help with not only blood sugar management, but with weight loss and heart health too Can Higher-Dose Trulicity Pack a Stronger Punch Than Currently Approved Doses